Therapeutic Area | MeSH |
---|---|
cardiovascular diseases | D002318 |
Brand Name | Status | Last Update |
---|---|---|
nebivolol | ANDA | 2022-12-01 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
malignant hypertension | EFO_1001031 | D006974 | — |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 2 | 4 | 15 | 33 | 14 | 66 |
Heart failure | D006333 | HP_0001635 | I50 | — | — | 1 | 8 | 5 | 14 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | — | 5 | — | 5 |
Diastolic heart failure | D054144 | EFO_1000899 | I50.30 | — | — | — | 3 | — | 3 |
Prehypertension | D058246 | — | — | — | — | — | 3 | — | 3 |
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | — | 1 | 2 | 3 |
Blood pressure | D001794 | EFO_0004325 | — | — | — | — | 1 | 1 | 2 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | 2 | — | 2 |
Coronary artery disease | D003324 | — | I25.1 | — | — | — | 2 | — | 2 |
Left ventricular dysfunction | D018487 | — | — | — | — | 1 | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Covid-19 | D000086382 | — | U07.1 | — | — | 1 | — | 1 | 2 |
Marfan syndrome | D008382 | Orphanet_558 | Q87.4 | — | — | 1 | — | — | 1 |
Cardiomyopathies | D009202 | EFO_0000318 | I42 | — | — | 1 | — | — | 1 |
Duchenne muscular dystrophy | D020388 | EFO_0000429 | — | — | — | 1 | — | — | 1 |
Peripheral arterial disease | D058729 | EFO_0004265 | — | — | — | 1 | — | — | 1 |
Pulmonary arterial hypertension | D000081029 | — | — | — | — | 1 | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | 1 | — | — | 1 |
Cardiotoxicity | D066126 | EFO_1001482 | — | — | — | 1 | — | — | 1 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Essential hypertension | D000075222 | — | I10 | — | 1 | — | — | 1 | 2 |
Ischemic stroke | D000083242 | — | — | — | 1 | — | — | — | 1 |
Myocardial bridging | D054084 | — | — | — | 1 | — | — | — | 1 |
Ocular hypertension | D009798 | EFO_1001069 | H40.0 | — | 1 | — | — | — | 1 |
Open-angle glaucoma | D005902 | EFO_0004190 | H40.1 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Osteoporosis | D010024 | HP_0000939 | M81.0 | 1 | — | — | — | — | 1 |
Idiopathic pulmonary fibrosis | D054990 | — | J84.112 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic renal insufficiency | D051436 | — | N18 | — | — | — | — | 1 | 1 |
Exercise test | D005080 | EFO_0004328 | — | — | — | — | — | 1 | 1 |
Hypersensitivity | D006967 | HP_0012393 | T78.40 | — | — | — | — | 1 | 1 |
Kidney transplantation | D016030 | — | — | — | — | — | — | 1 | 1 |
Hot flashes | D019584 | — | — | — | — | — | — | 1 | 1 |
Heart rate | D006339 | EFO_0004326 | — | — | — | — | — | 1 | 1 |
Pure autonomic failure | D054970 | — | — | — | — | — | — | 1 | 1 |
Multiple system atrophy | D019578 | — | — | — | — | — | — | 1 | 1 |
Frailty | D000073496 | — | R53.1 | — | — | — | — | 1 | 1 |
Drug common name | Nebivolol |
INN | nebivolol |
Description | 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] is a member of the class of chromanes that is 2,2'-iminodiethanol in which one hydrogen attached to each hydroxy-bearing carbon is replaced by a 6-fluorochroman-2-yl group. It is an organofluorine compound, a secondary amino compound, a secondary alcohol, a diol and a member of chromanes. |
Classification | Small molecule |
Drug class | beta-blockers (propranolol type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1 |
PDB | — |
CAS-ID | 99200-09-6 |
RxCUI | — |
ChEMBL ID | CHEMBL434394 |
ChEBI ID | 64019 |
PubChem CID | 71301 |
DrugBank | DB04861 |
UNII ID | 030Y90569U (ChemIDplus, GSRS) |